Kentucky Department for Public Health announces COVID-19 vaccine distribution draft plan

Grant Boone
October 18, 2020

If there's a sufficient supply, ME says it would have the capacity to vaccinate 80 percent of the state's 1.3 million people within 12 weeks of when a vaccine becomes available.

The US agency, which is rising the vaccine along with Germany's BioNTech SE, has mentioned it'd perceive on the finish of the month whether or not its merchandise was highly effective.

Many manufacturers are making headway in the race for a coronavirus disease 2019 (COVID-19) vaccine, with about 5 players in phase 3 trials, said Michael Haydock, senior director of content for cardiovascular and metabolic and infectious diseases at Informa Pharma Intelligence.

"For months, it's been necessary to remind Kentuckians that there is no cure for COVID-19 and that no vaccine exists".

Gov. Jared Polis set a hopeful timetable of late November as being when Colorado could get emergency authorization of a vaccine, which would be prioritized for frontline workers and nursing home residents.

The U.S. Centers for Disease Control and Prevention required each state to file by Friday a distribution plan outlining how it will get a vaccine from a manufacturer to doctors' offices and into patients' arms. "While there is work to be done, the submission of this document represents a positive step forward".

Stripe Acquires Paystack for $200M+, the Biggest Ever Startup Acquisition in Nigeria
I'm driven by the mission to accelerate payments on the continent, and I am convinced that Stripe will help us get there faster . Paystack will continue to operate independently, growing their operations in Africa and adding more global payment methods.

According to the 77-page plan, the strategy focuses on equity - because Maine's minority communities and those with certain health conditions have been disproportionately affected by COVID-19 - accessibility and flexibility. Some require multiple doses and others require ultra-cold storage.

According to her, when a Covid-19 vaccine becomes available, everybody will not have access to it initially as the supply is expected to be limited.

Pfizer and BioNTech's vaccine candidate, BNT162b2, is now being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina.

What's more, "from the contact tracing reports from various municipalities and states, the worry is that the spread is driven now, by indoor social gatherings in people's homes", he added, as the focus of social life shifts from public to private spaces in the colder weather. "The plan includes strategies to ensure these groups are successfully vaccinated", the Maine Department of Health and Human Services said in its news release.

The North American pharmaceutical company Pfizer hopes to request a emergency authorization for the use of your COVID-19 vaccine by the end of November, as announced on Thursday by the CEO of the company, Albert Bourla, in a open letter. Whichever version is approved will affect Maine's plan, and who will receive the vaccine first. When you've submitted your account email, we will send an email with a reset code.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER